Search

Your search keyword '"Sullman, Mark"' showing total 302 results
Start Over Author "Sullman, Mark" Search Limiters Academic (Peer-Reviewed) Journals
302 results on '"Sullman, Mark"'

7. Why people make friends: Evidence from 12 nations

Author

Apostolou, Menelaos, Sullman, Mark J.M., Ayers, Jessica D., Błachnio, Agata, Choubisa, Rajneesh, Gadelrab, Hesham F., Hill, Tetiana, Kamble, Shanmukh, Lisun, Yanina, Manrique-Millones, Denisse, Millones-Rivalles, Rosa, Ohtsubo, Yohsuke, Przepiórka, Aneta, Tekeş, Burcu, Cruz, Germano Vera, Wang, Yan, Watanabe, Yukino, and Ghorbani, Arya

Published
2024
Full Text
View/download PDF

38. The burden of major depressive disorder in the Middle East and North Africa region, 1990–2019.

Author

Safiri, Saeid, Mousavi, Seyed Ehsan, Nejadghaderi, Seyed Aria, Noori, Maryam, Sullman, Mark J. M., Kolahi, Ali-Asghar, and Shekarriz-Foumani, Reza

Subjects
MENTAL depression, GLOBAL burden of disease, AGE groups
Abstract

Background: Major depressive disorder (MDD) is one of the leading causes of disability. We aimed to report the MDD-attributable prevalence, incidence and years lived with disability (YLDs) in the Middle East and North Africa (MENA) region from 1990 to 2019 by age, sex and socio-demographic index (SDI). Methods: Publicly available data on the burden of MDD were retrieved from the Global Burden of Disease (GBD) study 2019 for the 21 countries in MENA. The counts and age-standardised rates (per 100,000) were presented, along with their corresponding 95% uncertainty intervals. Results: In 2019, MDD had an age-standardised point prevalence of 3322.1 and an incidence rate of 4921.7 per 100,000 population in MENA. Furthermore, there were 4.1 million YLDs in 2019. However, there were no substantial changes in the MDD burden over the period 1990–2019. In 2019, Palestine had the highest burden of MDD. The highest prevalence, incidence and YLDs attributable to MDD were found in the 35–39 age group. In 2019, the YLD rate in MENA was higher than the global rate for almost all age groups. Furthermore, there was a broadly negative association between the YLD rate and SDI. Conclusion: The study highlights the need to prevent the disorder using a multidisciplinary approach and for the provision of cost-effective treatments for those affected, in order to increase their quality of life. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

39. The efficacy and safety of Nigella sativa in the management of osteoarthritis: A systematic review.

Author

Mousavi, Seyed Ehsan, Noori, Maryam, Marandi, Hanieh, Fazlollahi, Asra, Nejadghaderi, Seyed Aria, Rahmani, Shayan, Noordoost, Mahdi, Karamzad, Nahid, Sullman, Mark J. M., Kolahi, Ali‐Asghar, and Safiri, Saeid

Subjects
BLACK cumin, KNEE pain, ORAL drug administration, OSTEOARTHRITIS, TOPICAL drug administration, RANDOMIZED controlled trials, OLDER people
Abstract

Background and Aims: Osteoarthritis (OA) is one of the most common debilitating diseases among the aging population. Nigella sativa is one potential treatment for OA. Here, we sought to evaluate the efficacy and safety of Nigella sativa for treating patients with OA. Methods: PubMed, Scopus, Embase, and Web of Science were searched up to October 20, 2022. The primary outcome was changes in the pain score after receiving Nigella sativa or control agents based on the results of randomized controlled trials (RCTs). The secondary outcome was set as the frequency of adverse events reported during the follow‐up period. Results: Six RCTs involving a total of 370 patients with knee OA were included in the present systematic review. Among the four screened studies, the topical administration of Nigella sativa oil was found to be more effective than the placebo in relieving pain in three trials. Additionally, the oral use of Nigella sativa oil was assessed in two trials, and an improvement in pain score relative to placebo was documented in only one of the studies. Also, the trial that evaluated the effectiveness of Nigella sativa oral capsules did not demonstrate any difference in pain reduction between the intervention and placebo groups. Overall, either topical or oral administration of Nigella sativa was well tolerated, and no serious adverse events were reported. Conclusion: Nigella sativa is generally safe, but conflicting findings from low‐quality studies hinder the ability to make clinical recommendations for or against treating OA. Robust trials are needed for informed decisions. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

44. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Author

Safiri, Saeid, Sepanlou, Sadaf G, Ikuta, Kevin S, Bisignano, Catherine, Salimzadeh, Hamideh, Delavari, Alireza, Ansari, Reza, Roshandel, Gholamreza, Merat, Shahin, Fitzmaurice, Christina, Force, Lisa M, Nixon, Molly R, Abbastabar, Hedayat, Abegaz, Kedir Hussein, Afarideh, Mohsen, Ahmadi, Ayat, Ahmed, Muktar Beshir, Akinyemiju, Tomi, Alahdab, Fares, Ali, Raghib, Alikhani, Mahtab, Alipour, Vahid, Aljunid, Syed Mohamed, Almadi, Majid Abdulrahman Hamad, Almasi-Hashiani, Amir, Al-Raddadi, Rajaa M, Alvis-Guzman, Nelson, Amini, Saeed, Anber, Nahla Hamed, Ansari-Moghaddam, Alireza, Arabloo, Jalal, Arefi, Zohreh, Asghari Jafarabadi, Mohammad, Azadmehr, Abbas, Badawi, Alaa, Baheiraei, Nafiseh, Bärnighausen, Till Winfried, Basaleem, Huda, Behzadifar, Masoud, Behzadifar, Meysam, Belayneh, Yaschilal Muche, Berhe, Kidanemaryam, Bhattacharyya, Krittika, Biadgo, Belete, Bijani, Ali, Biondi, Antonio, Bjørge, Tone, Borzì, Antonio M, Bosetti, Cristina, Bou-Orm, Ibrahim R., Brenner, Hermann, Briko, Andrey Nikolaevich, Briko, Nikolay Ivanovich, Carreras, Giulia, Carvalho, Félix, Castañeda-Orjuela, Carlos A, Cerin, Ester, Chiang, Peggy Pei-Chia, Chido-Amajuoyi, Onyema Greg, Daryani, Ahmad, Davitoiu, Dragos Virgil, Demoz, Gebre Teklemariam, Desai, Rupak, Dianati nasab, Mostafa, Eftekhari, Aziz, El Sayed, Iman, Elbarazi, Iffat, Emamian, Mohammad Hassan, Endries, Aman Yesuf, Esmaeilzadeh, Firooz, Esteghamati, Alireza, Etemadi, Arash, Farzadfar, Farshad, Fernandes, Eduarda, Fernandes, João C, Filip, Irina, Fischer, Florian, Foroutan, Masoud, Gad, Mohamed M, Gallus, Silvano, Ghaseni-Kebria, Fatemeh, Ghashghaee, Ahmad, Gorini, Giuseppe, Hafezi-Nejad, Nima, Haj-Mirzaian, Arvin, Haj-Mirzaian, Arya, Hasanpour-Heidari, Susan, Hasanzadeh, Amir, Hassanipour, Soheil, Hay, Simon I, Hoang, Chi Linh, Hostiuc, Mihaela, Househ, Mowafa, Ilesanmi, Olayinka Stephen, Ilic, Milena D., Innos, Kaire, Irvani, Seyed Sina Naghibi, Islami, Farhad, Jaca, Anelisa, Jafari Balalami, Nader, Jafari delouei, Nastaran, Jafarinia, Morteza, Jahani, Mohammad Ali, Jakovljevic, Mihajlo, James, Spencer L., Javanbakht, Mehdi, Jenabi, Ensiyeh, Jha, Ravi Prakash, Joukar, Farahnaz, Kasaeian, Amir, Kassa, Tesfaye Dessale, Kassaw, Mesfin Wudu, Kengne, Andre Pascal, Khader, Yousef Saleh, Khaksarian, Mojtaba, Khalilov, Rovshan, Khan, Ejaz Ahmad, Khayamzadeh, Maryam, Khazaee-Pool, Maryam, Khazaei, Salman, Khosravi Shadmani, Fatemeh, Khubchandani, Jagdish, Kim, Daniel, Kisa, Adnan, Kisa, Sezer, Kocarnik, Jonathan M, Komaki, Hamidreza, Kopec, Jacek A, Koyanagi, Ai, Kuipers, Ernst J., Kumar, Vivek, La Vecchia, Carlo, Lami, Faris Hasan, Lopez, Alan D, Lopukhov, Platon D, Lunevicius, Raimundas, Majeed, Azeem, Majidinia, Maryam, Manafi, Amir, Manafi, Navid, Manda, Ana-Laura, Mansour-Ghanaei, Fariborz, Mantovani, Lorenzo Giovanni, Mehta, Dhruv, Meier, Toni, Meles, Hagazi Gebre, Mendoza, Walter, Mestrovic, Tomislav, Miazgowski, Bartosz, Miazgowski, Tomasz, Mir, Seyed Mostafa, Mirzaei, Hamed, Mohammad, Karzan Abdulmuhsin, Mohammad Gholi Mezerji, Naser, Mohammadian-Hafshejani, Abdollah, Mohammadoo-Khorasani, Milad, Mohammed, Shafiu, Mohebi, Farnam, Mokdad, Ali H, Monasta, Lorenzo, Moossavi, Maryam, Moradi, Ghobad, Moradpour, Farhad, Moradzadeh, Rahmatollah, Nahvijou, Azin, Naik, Gurudatta, Najafi, Farid, Nazari, Javad, Negoi, Ionut, Nguyen, Cuong Tat, Nguyen, Trang Huyen, Ningrum, Dina Nur Anggraini, Ogbo, Felix Akpojene, Olagunju, Andrew T, Olagunju, Tinuke O, Pana, Adrian, Pereira, David M., Pirestani, Majid, Pourshams, Akram, Poustchi, Hossein, Qorbani, Mostafa, Rabiee, Mohammad, Rabiee, Navid, Radfar, Amir, Rahmati, Marveh, Rajati, Fatemeh, Rawaf, David Laith, Rawaf, Salman, Reiner, Robert C, Jr., Renzaho, Andre M N, Rezaei, Nima, Rezapour, Aziz, Saad, Anas M, Saadatagah, Seyedmohammad, Saddik, Basema, Salehi, Farkhonde, Salehi Zahabi, Saleh, Salz, Inbal, Samy, Abdallah M, Sanabria, Juan, Santric Milicevic, Milena M, Sarveazad, Arash, Satpathy, Maheswar, Schneider, Ione J C, Sekerija, Mario, Shaahmadi, Faramarz, Shabaninejad, Hosein, Shamsizadeh, Morteza, Sharafi, Zeinab, Sharif, Mehdi, Sharifi, Amrollah, Sheikhbahaei, Sara, Shirkoohi, Reza, Siddappa Malleshappa, Sudeep K, Silva, Diego Augusto Santos, Sisay, Mekonnen, Smarandache, Catalin-Gabriel, Soofi, Moslem, Soreide, Kjetil, Soshnikov, Sergey, Starodubov, Vladimir I., Subart, Michelle L., Sullman, Mark JM, Tabarés-Seisdedos, Rafael, Taherkhani, Amir, Tesfay, Berhe etsay, Topor-Madry, Roman, Traini, Eugenio, Tran, Bach Xuan, Tran, Khanh Bao, Ullah, Irfan, Uthman, Olalekan A, Vacante, Marco, Vahedian-Azimi, Amir, Valli, Alessandro, Varavikova, Elena, Vujcic, Isidora S, Westerman, Ronny, Yazdi-Feyzabadi, Vahid, Yisma, Engida, Yu, Chuanhua, Zadnik, Vesna, Zahirian Moghadam, Telma, Zaki, Leila, Zandian, Hamed, Zhang, Zhi-Jiang, Murray, Christopher J L, Naghavi, Mohsen, and Malekzadeh, Reza

Published
2019
Full Text
View/download PDF

46. Strategies for becoming a more desirable mate: Evidence from 14 countries.

Author

Apostolou, Menelaos, Sullman, Mark, Birkás, Béla, Błachnio, Agata, Bushina, Ekaterina, Calvo, Fran, Costello, William, Dujlovic, Tanja, Hill, Tetiana, Lisun, Yanina, Manrique-Millones, Denisse, Manrique-Pino, Oscar, Meskó, Norbert, Nechtelberger, Martin, Yohsuke Ohtsubo, Ollhoff, Christian Kenji, Przepiórka, Aneta, Putz, Ádám, Tagliabue, Mariaelena, and Tekeş, Burcu

Subjects
*SOCIAL status, *COUNTRIES
Abstract

The current research aimed to study the strategies that people employ in order to become more desirable as mates in different cultural settings. More specifically, using a closed-ended questionnaire on a sample of 7181 participants from 14 different countries, we identified 10 different strategies that people employ to become more appealing as mates. Participants indicated that they had more frequently used the "Enhance looks," followed by the "Show off abilities and talents," and the "Demonstrate similarity" strategies. On the other hand, they had less frequently used the "Keep undesirable things hidden," the "Show off and exaggerate wealth and abilities," and the "Drastic appearance changes" strategies. Female participants indicated that they had more extensive used the "Enhance looks" strategy than male participants, while male participants indicated that they had more extensive used the "Increase income and social status" and the "Show off and exaggerate wealth and abilities" strategies than female participants. The sex effects, as well as the extent of use, were generally consistent across the different cultures. The identified strategies were classified further into two main strategies, namely the "Develop and demonstrate desirable traits" and the "Deceive about undesirable traits," which was generally consistent across the different countries. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results